PepsiCo (NASDAQ: PEP) is scheduled to release its third-quarter earnings before the market opens on Thursday, October 8. The company's stock has been in a pronounced downtrend throughout 2026, and derivatives market activity suggests that the upcoming report may not provide much respite for investors.
Wall Street consensus projects earnings per share (EPS) of $2.29 on revenue of approximately $25 billion, which would represent a year-over-year top-line growth of about 4.2%. Despite these expectations, PEP shares have already fallen roughly 25% from their year-to-date high, reflecting persistent investor concerns.
Options Market Points to Further Declines
Data from Barchart indicates that the put-to-call ratio for contracts expiring on October 9 currently stands at 1.02, a level typically interpreted as bearish. The lower strike price on these options is set near $121, suggesting the potential for an additional 3% decline by the end of the week.
Technical analysis adds to the caution. PEP trades decisively below its key moving averages, and its Relative Strength Index (RSI) sits in the early 20s, signaling significant downward momentum that could persist in the near term.
Why Sentiment Is Dovish
The bearish options positioning likely stems from deteriorating volume growth and ongoing pressure on consumer spending. After years of aggressive price increases to offset inflation, PepsiCo is encountering resistance from value-conscious buyers who are either switching to private-label alternatives or reducing discretionary snack purchases.
Key segments, particularly Frito-Lay North America, are experiencing sluggish sales volumes, prompting Wall Street analysts to downgrade the stock due to market share losses. Additionally, shifting dietary trends, including the rising adoption of GLP-1 weight-loss medications, continue to weigh on long-term demand for packaged foods and sugary beverages.
With limited room for further price hikes, traders doubt that PepsiCo can deliver a top-line surprise strong enough to halt the share price decline.
Potential Upside for Patient Investors
Despite the prevailing gloom, some value-oriented investors see reasons for cautious optimism. The steep sell-off has compressed PepsiCo's valuation to attractive levels, with shares trading near multi-year low multiples. Moreover, the forward dividend yield has risen to approximately 4.7%, offering a significant income cushion for patient shareholders.
While Wall Street maintains a consensus "Hold" rating, the average 12-month price target of about $148 implies double-digit upside potential once volume metrics normalize. Unless Thursday's release uncovers unexpected operational weaknesses, PepsiCo's defensive balance sheet and reliable income profile may help establish a floor near current support levels.
This article is for informational purposes only and does not constitute financial advice.
